Novavax Continues to Deliver on Sanofi Partnership, Completing Nuvaxovid® EU Marketing Authorization Transfer and Triggering $25 Million Milestone Payment

Novavax, Inc. (Nasdaq: NVAX) has completed the transfer of the marketing authorization for its COVID-19 vaccine, Nuvaxovid® ...

Are the New COVID Vaccines Available, and Should You Get One? Experts Explain

The updated 2025-2026 COVID-19 vaccines are now widely available, but with some new limitations. Who can get the shot this ...
Zacks Investment Research on MSN

Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know

Novavax (NVAX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

Novavax hands over Nuvaxovid marketing rights to Sanofi in the EU

Novavax transfers EU rights for Nuvaxovid to Sanofi, earning milestone payments and future royalties. Read more here.

CDC signs off on fall Covid shots. It may not be easy to get one, depending on where you live

The federal guidance comes after many states have already announced their own Covid vaccine recommendations, creating ...

Novavax expects delayed U.S. COVID-19 vaccine trial to start in coming weeks

Novavax Inc on Monday pushed back the start of a U.S.-based, late-stage trial for its experimental COVID-19 vaccine for the second time and now expects it to begin in the coming weeks instead of ...

A Fresh Look at Novavax (NVAX) Valuation After Recent Share Price Rebound

Novavax (NVAX) has caught the attention of investors this month, as its stock climbed over 26% in the past 30 days. The company’s performance draws curiosity about what might be fueling the move, ...
Zacks Investment Research on MSN

Novavax (NVAX) Exceeds Market Returns: Some Facts to Consider

Novavax (NVAX) ended the recent trading session at $8.67, demonstrating a +1.17% change from the preceding day's closing price. This change outpaced the S&P 500's 0.41% gain on the day. At the same ...

After distribution delay, vaccines due to arrive this week, Mass. public health chief says

Public Health Commissioner Dr. Robbie Goldstein says purchasing began immediately after a drawn-out federal process.

CDC recommends coronavirus vaccine with a new caveat. Here’s what to know.

The Centers for Disease Control and Prevention on Monday officially recommended updated coronavirus vaccines, creating a new ...

Who can actually get a COVID-19 vaccine? Navigating the latest recommendations

GoodRx reports that CDC now recommends COVID-19 vaccinations be decided with healthcare professionals, stressing personalized ...

Novavax delays U.S. trial of COVID-19 vaccine to November

Novavax Inc on Tuesday delayed the start of a late-stage U.S. trial of its experimental coronavirus vaccine by roughly a month to the end of November, citing delays in scaling up the manufacturing ...